(Q34777373)

4 August 2017

1 reference

title

Pharmacogenomics of the response to IFN-beta in multiple sclerosis: ramifications from the first genome-wide screen (English)

1 reference

4 August 2017

0 references

1 reference

Koen Vandenbroeck

1

0 references

Carlos Matute

object named as

Carlos Matute

series ordinal

2

0 references

publication date

1 May 2008

1 reference

4 August 2017

1 reference

4 August 2017

9

1 reference

4 August 2017

5

1 reference

4 August 2017

639-645

1 reference

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

4 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Multiple sclerosis therapy monitoring based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Genome-wide network analysis reveals the global properties of IFN-beta immediate transcriptional effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

HLA class II and response to interferon-beta in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Glutamate-mediated glial injury: mechanisms and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Lysosomal cysteine proteases regulate antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

European population substructure: clustering of northern and southern populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

The prevalence of multiple sclerosis in the world: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.5.639

21 January 2018

Identifiers

DOI

10.2217/14622416.9.5.639

1 reference

4 August 2017

1 reference

PubMed ID

18466107